| Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study DQ Huang, LA Wilson, C Behling, DE Kleiner, KV Kowdley, S Dasarathy, ... Gastroenterology 165 (2), 463-472. e5, 2023 | 55 | 2023 |
| Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis DQ Huang, N Noureddin, V Ajmera, M Amangurbanova, R Bettencourt, ... The Lancet Gastroenterology & Hepatology 8 (9), 829-836, 2023 | 35 | 2023 |
| Hepatocellular carcinoma incidence in alcohol-associated cirrhosis: systematic review and meta-analysis DQ Huang, DJH Tan, CH Ng, M Amangurbanova, N Sutter, PWL Tay, ... Clinical Gastroenterology and Hepatology 21 (5), 1169-1177, 2023 | 28 | 2023 |
| Clinical utility of combined MRI-PDFF and ALT response in predicting histologic response in nonalcoholic fatty liver disease DQ Huang, SR Sharpton, M Amangurbanova, N Tamaki, CB Sirlin, ... Clinical Gastroenterology and Hepatology 21 (10), 2682-2685. e4, 2023 | 22 | 2023 |
| the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD M Amangurbanova, DQ Huang, R Loomba Alimentary pharmacology & therapeutics 57 (1), 37-51, 2023 | 22 | 2023 |
| Comprehensive review of cardiovascular complications of coronavirus disease 2019 and beneficial treatments FK Welty, N Rajai, M Amangurbanova Cardiology in review 30 (3), 145-157, 2022 | 19 | 2022 |
| ω-3 Ethyl ester results in better cognitive function at 12 and 30 months than control in cognitively healthy subjects with coronary artery disease: a secondary analysis of a … A Malik, A Ramadan, B Vemuri, W Siddiq, M Amangurbanova, A Ali, ... The American Journal of Clinical Nutrition 113 (5), 1168-1176, 2021 | 18 | 2021 |
| Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes SZ Kuo, S Cepin, J Bergstrom, H Siddiqi, J Jung, S Lopez, DQ Huang, ... Alimentary pharmacology & therapeutics 58 (6), 585-592, 2023 | 12 | 2023 |
| Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality SW Lee, DQ Huang, R Bettencourt, V Ajmera, M Tincopa, N Noureddin, ... Alimentary pharmacology & therapeutics 59 (1), 80-88, 2024 | 7 | 2024 |
| Development and validation of the nonalcoholic fatty liver disease familial risk score to detect advanced fibrosis: a prospective, multicenter study DQ Huang, N Ahlholm, PK Luukkonen, K Porthan, M Amangurbanova, ... Clinical Gastroenterology and Hepatology 22 (1), 81-90. e4, 2024 | 7 | 2024 |
| MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH R Loomba, M Amangurbanova, R Bettencourt, E Madamba, H Siddiqi, ... Gut, 2024 | 5 | 2024 |
| Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non‐alcoholic fatty liver disease: an individual participant‐level data meta‐analysis … DQ Huang, N Noureddin, V Ajmera, M Amangurbanova, R Bettencourt, ... DOI: https://doi. org/10.1016/S2468-1253 (23), 00157-7, 0 | 5 | |
| Docosahexaenoic acid Levels and omega-3 index, but not eicosapentaenoic acid levels, are associated with improved cognition in cognitively healthy subjects with coronary artery … G Chedid, A Malik, M Amangurbanova, H Khraishah, FK Welty Arteriosclerosis, thrombosis, and vascular biology 43 (2), 382-384, 2023 | 4 | 2023 |
| Regression of coronary fatty plaque and risk of cardiac events according to blood pressure status: data From a randomized trial of eicosapentaenoic acid and docosahexaenoic … FK Welty, E Hariri, AA Asbeutah, R Daher, M Amangurbanova, G Chedid, ... Journal of the American Heart Association 12 (18), e030071, 2023 | 2 | 2023 |
| Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized … E Hariri, AA Asbeutah, A Malik, M Amangurbanova, G Chedid, R Daher, ... Atherosclerosis 387, 117388, 2023 | 1 | 2023 |
| Higher epicardial adipose tissue volume is associated with higher coronary fatty plaque volume and is regulated by waist circumference but not EPA+ DHA supplementation M Amangurbanova, R Daher, AA Asbeutah, B Vemuri, H Mirza, ... Journal of Clinical Lipidology, 2024 | | 2024 |
| Repeatability of vibration‐controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study H Siddiqi, DQ Huang, N Mittal, N Nourredin, R Bettencourt, E Madamba, ... Alimentary Pharmacology & Therapeutics, 2024 | | 2024 |
| WED-235 Prediction of metabolic dysfunction-associated steatohepatitis resolution R Loomba, M Amangurbanova, R Bettencourt, E Madamba, H Siddiqi, ... Journal of Hepatology 80, S522-S523, 2024 | | 2024 |
| Mo1514 PREVALENCE OF MASLD, METALD, ALD AND CIRRHOSIS AMONG OVERWEIGHT AND OBESE INDIVIDUALS IN THE UNITED STATES: A PROSPECTIVE STUDY AH Yang, MA Tincopa, VH Ajmera, LM Richards, M Amangurbanova, ... Gastroenterology 166 (5), S-1675, 2024 | | 2024 |
| Su1613 REPEATABILITY OF VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY VERSUS MAGNETIC RESONANCE ELASTOGRAPHY IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE STUDY H Siddiqi, D Huang, N Mittal, N Noureddin, R Bettencourt, E Madamba, ... Gastroenterology 166 (5), S-1664-S-1665, 2024 | | 2024 |
